• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Relay Therapeutics, Inc. - Common Stock (NQ:RLAY)

    8.990 +0.340 (+3.93%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,874,698
    Open 8.680
    Bid (Size) 8.680 (7,500)
    Ask (Size) 9.000 (1,700)
    Prev. Close 8.650
    Today's Range 8.630 - 9.245
    52wk Range 1.775 - 9.190
    Shares Outstanding 121,613,181
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Relay Therapeutics Insider Sells 21,000 Shares for $166,700 After 65% Run ↗
    This clinical-stage biotech focused on precision oncology therapies reported an insider sale amid a year of sharp share price gains. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
    From Relay Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +9.9%
    +9.9%
    1 Month
    +15.3%
    +15.3%
    3 Month
    +45.7%
    +45.7%
    6 Month
    +176.6%
    +176.6%
    1 Year
    +124.2%
    +124.2%

    More News

    Read More
    News headline image
    Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 7, 2025 ↗
    Via Benzinga
    News headline image
    Preview: Relay Therapeutics's Earnings ↗
    Via Benzinga
    News headline image
    The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
    Via MarketMinute
    Topics ETFs Government Initial Public Offering
    News headline image
    Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
    From Equity Insider
    Via GlobeNewswire
    News headline image
    Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestrant in Breast Cancer Patients Pre-Treated with SERD or with ESR1 Mutations at SABCS 2025
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Relay Therapeutics Director Sells $300,000 Worth of Shares. Here's Why Investors Shouldn't Panic. ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture
    Via TokenRing AI
    Topics Artificial Intelligence Economy Emissions
    News headline image
    Relay Therapeutics Inc (NASDAQ:RLAY) Reports Q3 2025 Earnings Miss and Clinical Progress ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Why Relay Therapeutics Stock Rocketed Nearly 15% Higher This Week ↗
    Via The Motley Fool
    News headline image
    Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Medtronic To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
    Via Benzinga
    News headline image
    Relay (RLAY) Q2 Loss Narrows 41% ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June
    From Relay Therapeutics, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Relay Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Relay Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Relay Therapeutics, Inc. - Common Stock trade on?
    Relay Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Relay Therapeutics, Inc. - Common Stock?
    The ticker symbol for Relay Therapeutics, Inc. - Common Stock is RLAY on the Nasdaq Stock Market
    What is the current price of Relay Therapeutics, Inc. - Common Stock?
    The current price of Relay Therapeutics, Inc. - Common Stock is 8.990
    When was Relay Therapeutics, Inc. - Common Stock last traded?
    The last trade of Relay Therapeutics, Inc. - Common Stock was at 02/10/26 04:00 PM ET
    What is the market capitalization of Relay Therapeutics, Inc. - Common Stock?
    The market capitalization of Relay Therapeutics, Inc. - Common Stock is 1.09B
    How many shares of Relay Therapeutics, Inc. - Common Stock are outstanding?
    Relay Therapeutics, Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.